Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers C > Headlines for Chelsea Therapeutics International, Ltd. > News item |
El Coronado investors report owning 19.68% of Chelsea Therapeutics
By Lisa Kerner
Charlotte, N.C., July 24 - Chelsea Therapeutics International Ltd. investors led by El Coronado Holdings, LLC and Josiah T. Austin purchased 394,805 shares of the company's stock between July 3 and July 20, priced between $6.37 and $6.98 per share.
The reporting persons beneficially own 4,514,637 shares, or 19.68%, of the Charlotte, N.C., development-stage pharmaceutical company, according to a schedule 13D filing with the Securities and Exchange Commission.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.